Myeloma is a clonal malignancy of plasma cells. Poor prognosis risk is currently identified by clinical and cytogenetic features. However, these indicators do not capture all prognostic information.
Multiple myeloma data. Survival data from the multiple myeloma example used in this paper, including the donor KIR haplotype, event times and types (0 = censored, 1 = relapse, 2 = transplant-related d
Abstract Background: TMEM97 has been proven to be involved in many biological processes of malignancies. This study was designed to investigate the role of TMEM97 in multiple myeloma progression and